Reuters logo
BRIEF-Mustang Bio enters lease agreement for production of Car T therapies
October 30, 2017 / 12:10 PM / in 19 days

BRIEF-Mustang Bio enters lease agreement for production of Car T therapies

Oct 30 (Reuters) - Fortress Biotech Inc

* Entered lease agreement for manufacturing facility to support clinical development, commercialization of co’s Car T product candidates​

* Facility is expected to be operational for production of personalized Car T therapies in 2018​

* Has entered into a lease agreement with UMASS Medicine Science Park in Worcester, Massachusetts​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below